Altimmune, Inc. (ALT): Price and Financial Metrics
ALT Price/Volume Stats
Current price | $6.74 | 52-week high | $14.84 |
Prev. close | $6.74 | 52-week low | $2.32 |
Day low | $6.62 | Volume | 2,128,400 |
Day high | $7.20 | Avg. volume | 3,787,003 |
50-day MA | $6.76 | Dividend yield | N/A |
200-day MA | $7.72 | Market Cap | 479.02M |
ALT Stock Price Chart Interactive Chart >
Altimmune, Inc. (ALT) Company Bio
Altimmune, Inc., a clinical stage biopharmaceutical company, focused developing treatments for liver disease, immune modulating therapies, and vaccines. The company develops HepTcell, an immunotherapeutic product candidate that has completed Phase I clinical trial for patients chronically infected with the hepatitis B virus; NasoShield, an anthrax vaccine to provide for protection after a single intranasal administration; NasoVAX, a recombinant intranasal vaccine product candidate; and AdCOVID, a single-dose intranasal vaccine to protect against COVID-19 Its preclinical stage products include ALT-801, a novel peptide-based dual GLP-1/Glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis; and ALT-702, an investigational tumor immunostimulant for treating cancer. The company also develops veterinary product candidates. It has a collaboration with the University of Alabama at Birmingham for the development of AdCOVID. Altimmune, Inc. is headquartered in Gaithersburg, Maryland.
ALT Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | N/A |
5-year | N/A |
YTD | N/A |
2023 | N/A |
2022 | N/A |
2021 | N/A |
2020 | N/A |
2019 | N/A |
Continue Researching ALT
Here are a few links from around the web to help you further your research on Altimmune Inc's stock as an investment opportunity:Altimmune Inc (ALT) Stock Price | Nasdaq
Altimmune Inc (ALT) Stock Quote, History and News - Yahoo Finance
Altimmune Inc (ALT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...